2023-03-30T16:58:22+08:00 weekly 1.0 https://sk.prisysbiotech.com/ 2024-11-09T10:35:18+08:00 weekly 0.9 https://sk.prisysbiotech.com/ophthalmic-disease-research 2024-11-09T10:35:07+08:00 weekly 0.9 https://sk.prisysbiotech.com/hematological-disease-research 2024-11-09T10:35:13+08:00 weekly 0.9 https://sk.prisysbiotech.com/respiratory-disease-research 2023-04-01T19:57:31+08:00 weekly 0.9 https://sk.prisysbiotech.com/co-develop 2024-11-09T10:35:16+08:00 weekly 0.9 https://sk.prisysbiotech.com/inflammation-immunology-disorders 2024-11-09T10:35:16+08:00 weekly 0.9 https://sk.prisysbiotech.com/cns-disorders-behavior-analysis 2024-11-09T10:35:15+08:00 weekly 0.9 https://sk.prisysbiotech.com/metabolic-syndromes-research 2024-11-09T10:35:10+08:00 weekly 0.9 https://sk.prisysbiotech.com/translational-research-center 2024-11-09T10:35:14+08:00 weekly 0.9 https://sk.prisysbiotech.com/animal-welfare 2026-08-08T18:46:47+08:00 weekly 0.9 https://sk.prisysbiotech.com/download 2024-09-29T14:45:25+08:00 weekly 0.9 https://sk.prisysbiotech.com/nephrology 2024-09-29T14:23:03+08:00 weekly 0.9 https://sk.prisysbiotech.com/fibrosis 2024-11-09T10:34:57+08:00 weekly 0.9 https://sk.prisysbiotech.com/about-us 2024-11-09T10:35:04+08:00 weekly 0.9 https://sk.prisysbiotech.com/contact-us 2023-04-01T19:57:31+08:00 weekly 0.9 https://sk.prisysbiotech.com/newslist-1 2024-11-09T10:34:56+08:00 weekly 0.9 https://sk.prisysbiotech.com/products 2026-02-07T02:37:28+08:00 weekly 0.9 https://sk.prisysbiotech.com/blog/ 2023-04-01T19:28:23+08:00 weekly 0.9 https://sk.prisysbiotech.com/translation-research/ 2023-04-01T19:28:23+08:00 weekly 1.0 https://sk.prisysbiotech.com/nhp-pharmacology/ 2023-04-01T19:28:24+08:00 weekly 0.9 https://sk.prisysbiotech.com/safety-evaluation/ 2023-04-01T19:28:24+08:00 weekly 0.9 https://sk.prisysbiotech.com/biosafety-research/ 2023-04-01T19:28:25+08:00 weekly 0.9 https://sk.prisysbiotech.com/pk-pd-adme/ 2024-04-09T12:51:45+08:00 weekly 0.9 https://sk.prisysbiotech.com/clearpoint/ 2024-11-09T10:35:14+08:00 weekly 0.8 https://sk.prisysbiotech.com/nhp-pharmacology/the-nhp-pharmacology-of-prisys.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://sk.prisysbiotech.com/nhp-pharmacology/non-human-primate.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://sk.prisysbiotech.com/safety-evaluation/single-dose-repeated-dose-toxicity-testing.html 2024-11-09T10:35:07+08:00 weekly 0.8 https://sk.prisysbiotech.com/pk-pd-adme/toxicokinetics.html 2024-11-09T10:35:03+08:00 weekly 0.8 https://sk.prisysbiotech.com/safety-evaluation/dose-range-finding-test.html 2026-08-13T17:41:05+08:00 weekly 0.8 https://sk.prisysbiotech.com/nhp-pharmacology/what-is-a-nhp-study.html 2024-11-09T10:35:10+08:00 weekly 0.8 https://sk.prisysbiotech.com/nhp-pharmacology/nhp-non-alcoholic-steatohepatitis-nash-model.html 2024-11-09T10:35:11+08:00 weekly 0.8 https://sk.prisysbiotech.com/biosafety-research/biosafetyresearch.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://sk.prisysbiotech.com/safety-evaluation/new-and-modified-applications.html 2024-11-09T10:35:05+08:00 weekly 0.8 https://sk.prisysbiotech.com/nhp-pharmacology/nhp-asthma-atopic-dermatitis-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://sk.prisysbiotech.com/safety-evaluation/toxicology.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://sk.prisysbiotech.com/nhp-pharmacology/non-human-primate-model-renal-ischemia.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://sk.prisysbiotech.com/nhp-pharmacology/coagulation-hemostasis-nonhuman-primates.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://sk.prisysbiotech.com/nhp-pharmacology/nhp-chronic-obstructive-pulmonary-disease.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://sk.prisysbiotech.com/pk-pd-adme/adme.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://sk.prisysbiotech.com/nhp-pharmacology/heart-failure-nonhuman-primates-disease-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://sk.prisysbiotech.com/nhp-pharmacology/glaucoma-nonhuman-primates-disease-model.html 2024-11-09T10:35:15+08:00 weekly 0.8 https://sk.prisysbiotech.com/nhp-pharmacology/delayed-type-hypersensitivity-dth-nonhuman.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://sk.prisysbiotech.com/nhp-pharmacology/amd-nonhuman-primates-disease-model.html 2024-11-09T10:35:09+08:00 weekly 0.8 https://sk.prisysbiotech.com/nhp-pharmacology/tdar-nonhuman-primates-disease-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://sk.prisysbiotech.com/nhp-pharmacology/embolism-nonhuman-primates-disease-model.html 2024-11-09T10:35:05+08:00 weekly 0.8 https://sk.prisysbiotech.com/pk-pd-adme/pharmacokinetics.html 2024-11-09T10:35:11+08:00 weekly 0.8 https://sk.prisysbiotech.com/nhp-pharmacology/rheumatoid-arthritis-nhp-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://sk.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-nhp-disease-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://sk.prisysbiotech.com/nhp-pharmacology/multiple-sclerosis-nhp-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://sk.prisysbiotech.com/nhp-pharmacology/myopia-hyperopia-nhp-model.html 2024-11-09T10:35:07+08:00 weekly 0.8 https://sk.prisysbiotech.com/nhp-pharmacology/psoriasis-nonhuman-primates-disease-model.html 2024-11-09T10:35:01+08:00 weekly 0.8 https://sk.prisysbiotech.com/translation-research/nhpresources.html 2024-11-09T10:35:14+08:00 weekly 0.8 https://sk.prisysbiotech.com/nhp-pharmacology/nhp-lung-fibrosis-model.html 2024-11-09T10:35:05+08:00 weekly 0.8 https://sk.prisysbiotech.com/nhp-pharmacology/nhp-monkey-disease-models.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://sk.prisysbiotech.com/nhp-pharmacology/uveitis-nonhuman-primates-disease-model.html 2024-11-09T10:35:07+08:00 weekly 0.8 https://sk.prisysbiotech.com/pk-pd-adme/pharmacodynamics.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://sk.prisysbiotech.com/translation-research/translational-studies.html 2026-08-13T17:41:00+08:00 weekly 0.8 https://sk.prisysbiotech.com/safety-evaluation/immunotoxicity.html 2024-11-09T10:35:19+08:00 weekly 0.8 https://sk.prisysbiotech.com/nhp-pharmacology/mcao-nhp-model.html 2024-11-09T10:35:16+08:00 weekly 0.8 https://sk.prisysbiotech.com/nhp-pharmacology/hemophilia-a-nonhuman-primates-disease-model.html 2024-11-09T10:35:11+08:00 weekly 0.8 https://sk.prisysbiotech.com/nhp-pharmacology/neuropathic-pain-nhp-model.html 2024-11-09T10:35:19+08:00 weekly 0.8 https://sk.prisysbiotech.com/nhp-pharmacology/epilepsy-nhp-model.html 2024-11-09T10:35:38+08:00 weekly 0.8 https://sk.prisysbiotech.com/translation-research/ai-based-nhp-behavior-analysis-system.html 2024-11-09T11:03:56+08:00 weekly 0.8 https://sk.prisysbiotech.com/clearpoint/clearpoint-navigation-for-cns-research.html 2024-11-09T10:35:11+08:00 weekly 0.8 https://sk.prisysbiotech.com/nhp-pharmacology/parkinson-s-disease-model.html 2024-11-09T10:35:25+08:00 weekly 0.8 https://sk.prisysbiotech.com/translation-research/clinical-imaging.html 2024-09-30T21:35:42+08:00 weekly 0.8 https://sk.prisysbiotech.com/nhp-pharmacology/type-1-diabetes-mellitus-model.html 2024-11-09T10:35:29+08:00 weekly 0.8 https://sk.prisysbiotech.com/nhp-pharmacology/type-2-diabetes-mellitus-model.html 2024-09-30T21:35:44+08:00 weekly 0.8 https://sk.prisysbiotech.com/nhp-pharmacology/hyperlipoidemia-model.html 2024-09-30T21:35:46+08:00 weekly 0.8 https://sk.prisysbiotech.com/nhp-pharmacology/endometriosis-model.html 2024-09-30T21:35:46+08:00 weekly 0.8 https://sk.prisysbiotech.com/nhp-pharmacology/renal-fibrosis-model.html 2024-09-30T21:35:48+08:00 weekly 0.8 https://sk.prisysbiotech.com/nhp-pharmacology/immunosuppression-model.html 2024-09-30T21:35:55+08:00 weekly 0.8 https://sk.prisysbiotech.com/nhp-pharmacology/a-v-shunt-model.html 2024-12-08T17:10:32+08:00 weekly 0.8 https://sk.prisysbiotech.com/clearpoint/convection-enhanced-delivery-ced-technology.html 2024-12-12T17:20:48+08:00 weekly 0.8 https://sk.prisysbiotech.com/clearpoint/nhp-neuroscience.html 2025-04-01T18:25:05+08:00 weekly 0.8 https://sk.prisysbiotech.com/nhp-pharmacology/pruritus-nhp-model.html 2025-04-01T18:25:07+08:00 weekly 0.8 https://sk.prisysbiotech.com/nhp-pharmacology/atopic-dermatitis-nhp-model.html 2025-07-24T09:18:34+08:00 weekly 0.8 https://sk.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-disease-ibd-nhp-model.html 2025-07-24T09:05:17+08:00 weekly 0.8 https://sk.prisysbiotech.com/translation-research/targeted-organ-drug-delivery-platform-in-nhp.html 2025-08-25T11:10:23+08:00 weekly 0.8 https://sk.prisysbiotech.com/nhp-pharmacology/aav-synuclein-overexpression-nhp-model.html 2025-09-14T16:24:00+08:00 weekly 0.8 https://sk.prisysbiotech.com/nhp-pharmacology/heart-failure-nhp-model.html 2025-09-21T17:19:01+08:00 weekly 0.8 https://sk.prisysbiotech.com/nhp-pharmacology/acute-lung-inflammation-ali-nhp-model.html 2025-09-27T13:56:24+08:00 weekly 0.8 https://sk.prisysbiotech.com/pk-pd-adme/nose-to-brain-drug-delivery.html 2025-10-05T13:03:51+08:00 weekly 0.8 https://sk.prisysbiotech.com/nhp-pharmacology/acute-hemorrhagic-shock-model-nhp-model.html 2025-12-25T20:20:22+08:00 weekly 0.8 https://sk.prisysbiotech.com/nhp-pharmacology/retinitis-pigmentosa-rp-nhp-model.html 2026-01-29T22:42:44+08:00 weekly 0.8 https://sk.prisysbiotech.com/nhp-pharmacology/liver-fibrosis-model.html 2026-05-01T04:56:45+08:00 weekly 0.8 https://sk.prisysbiotech.com/translation-research/biodistribution-imaging-service.html 2026-05-01T04:56:27+08:00 weekly 0.8 https://sk.prisysbiotech.com/translation-research/dsa-guided-interventional-platform.html 2026-05-01T04:56:27+08:00 weekly 0.8 https://sk.prisysbiotech.com/pk-pd-adme/nhp-intracerebral-injection-icm-services.html 2026-05-01T04:56:29+08:00 weekly 0.8 https://sk.prisysbiotech.com/pk-pd-adme/nhp-intrathecal-dosing-csf-sampling.html 2026-05-25T20:10:56+08:00 weekly 0.8 https://sk.prisysbiotech.com/pk-pd-adme/nhp-intracerebroventricular-icv-injection.html 2026-05-25T20:10:48+08:00 weekly 0.8 https://sk.prisysbiotech.com/nhp-pharmacology/nhp-focal-segmental-glomerulosclerosis-fsgs.html 2023-04-01T19:28:23+08:00 weekly 0.9 https://sk.prisysbiotech.com/newslist-714606-1 2023-04-01T19:28:24+08:00 weekly 0.9 https://sk.prisysbiotech.com/newslist-714607-1 2024-08-01T09:02:39+08:00 weekly 0.9 https://sk.prisysbiotech.com/newslist-819437-1 2026-05-01T04:31:23+08:00 weekly 0.9 https://sk.prisysbiotech.com/newslist-17853531461297152-1 2026-09-10T15:42:22+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/meetprisys-sot2023-66154662.html 2026-09-10T15:42:22+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/prisys-sot2023-66154663.html 2026-09-10T15:42:22+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/prisys-celebrating-world-wildlife-day-66154664.html 2026-09-10T15:42:22+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/the-construction-of-prisys-shanghai-nhp-r-d-ce-66154665.html 2026-09-01T21:55:31+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/do-we-need-further-studies-for-pain-assessment-66154666.html 2026-09-10T15:42:22+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/supporting-women-s-health-a-look-into-endomet-66154667.html 2026-09-01T21:55:34+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/prisys-biotech-non-human-primate-pharmacology-66154668.html 2026-09-01T21:48:17+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/gene-therapy-nhp-model-66154669.html 2026-09-01T21:48:30+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/top-10-popular-questions-related-to-gene-thera-66154670.html 2026-09-01T21:48:17+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/dmpk-study-for-gene-therapy-66154671.html 2026-09-01T21:48:17+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/gene-therapy-toxicology-66275673.html 2026-09-01T22:02:42+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/maximizing-sirna-pharmacology-efficiency-67551582.html 2026-09-01T22:02:46+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/how-nonhuman-primates-can-revolutionize-sirna-67552229.html 2026-09-01T22:02:43+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/unleashing-the-therapeutic-potential-67552230.html 2026-09-01T22:02:44+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/maximizing-crispr-cas9-research-efficiency-wit-67565066.html 2026-09-10T15:42:22+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/celebrating-world-day-for-laboratory-animals-67571018.html 2026-09-01T21:48:20+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/nhp-effectively-in-gene-therapy-67571937.html 2026-09-10T15:42:22+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/world-parkinsons-disease-day-67582227.html 2026-09-01T22:02:46+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/unlocking-the-potential-of-nonhuman-primates-67593206.html 2026-09-01T22:02:43+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/revolutionizing-drug-discovery-nhp-68127529.html 2026-09-10T15:42:22+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/meet-prisys-biotech-at-70th-jalas-68127530.html 2026-09-01T21:55:31+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/why-you-should-care-about-non-human-primates-68127531.html 2026-09-01T22:02:51+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/gene-therapy-shines-with-new-approvals-for-rar-68127532.html 2026-09-01T21:48:17+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/an-optimal-animal-model-of-ischemic-stroke-est-68332360.html 2026-09-01T21:55:38+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/how-aav-gene-therapy-can-save-your-vision-the-69080634.html 2026-09-10T15:42:22+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/prisys-biotech-invites-you-to-participate-in-t-69081160.html 2026-09-01T21:55:38+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/immunotoxicity-test-drug-safety-evaluation-pr-69081651.html 2026-09-01T21:55:39+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/the-promising-future-of-aav-gene-therapy-in-no-69082788.html 2026-09-01T21:55:35+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/prisys-biotech-showcases-non-human-primate-mod-69086164.html 2026-09-01T21:55:39+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/what-are-lipid-nanoparticles-for-gene-therapy-69089366.html 2026-09-01T22:02:46+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/how-china-monkey-help-to-conduct-preclinical-r-69309270.html 2026-09-01T21:55:38+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/what-is-the-efficiency-of-rnai-69309271.html 2026-09-01T21:55:34+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/large-animal-experiment-public-service-platfor-69309334.html 2026-09-01T22:02:45+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/how-to-lose-weight-and-control-diabetes-with-g-69309379.html 2023-08-02T02:59:54+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/prisys-biotechnology-a-leader-in-nhp-cns-dise-69670771.html 2026-07-22T10:23:01+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/key-research-points-of-adc-drug-pk-69671096.html 2026-09-01T21:55:37+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/method-for-establishing-a-cynomolgus-monkey-mo-71078776.html 2026-09-01T21:55:46+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/0-71078777.html 2026-09-01T21:55:33+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/pharmacokinetics-research-strategies-and-case-71078778.html 2026-09-01T21:55:44+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/prisys-providing-high-quality-animal-experime-71078779.html 2026-09-01T21:55:41+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/preclinical-pharmacology-evaluation-of-oncolyt-71078780.html 2026-09-01T21:55:42+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/pharmacology-main-parameters-and-significance-71078781.html 2026-09-10T15:42:22+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/prisys-biotech-invites-you-to-attend-sapa-chin-72335912.html 2026-09-01T21:55:41+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/world-alzheimer-s-day-the-challenges-and-sol-72335913.html 2026-09-01T21:55:40+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/world-stroke-day-focus-on-ischemic-stroke-an-72335915.html 2026-09-10T15:42:22+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/meet-prisys-biotech-at-the-society-for-neurosc-72335916.html 2026-09-01T21:55:39+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-macaque-animal-mod-72336396.html 2026-09-10T15:42:22+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/exhibition-review-prisys-biotech-shines-at-t-72712008.html 2026-09-01T21:55:54+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/non-human-primates-a-brief-introduction-to-th-73030727.html 2026-09-01T21:55:38+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/how-ultrasound-guided-liver-biopsy-enhances-ma-73660212.html 2026-09-01T21:55:39+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/guidelines-for-lifetime-use-of-nonhuman-primat-73660632.html 2026-07-22T10:23:02+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/revolutionizing-cns-drug-delivery-prisys-and-74216598.html 2026-09-01T21:55:42+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/elevating-nucleic-acid-therapeutics-through-cu-74699554.html 2026-09-01T21:55:39+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/prisys-advancing-animal-experimentation-throu-74814213.html 2026-09-01T21:55:39+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/nonhuman-primate-study-newsletter-2024-q-75177064.html 2026-09-01T21:55:38+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/non-clinical-pharmacodynamics-research-an-ess-75177066.html 2026-09-01T21:55:39+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/prisys-achieves-full-accreditation-from-aaalac-76220233.html 2026-09-10T15:42:22+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/innovative-solutions-for-advancing-respiratory-77088582.html 2026-09-01T21:55:47+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/mri-guided-large-animal-central-nervous-system-77773010.html 2024-11-09T10:34:54+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/prisys-biotech-2024-q2-newsletter-77773013.html 2026-09-01T21:55:45+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/nhp-asthma-model-79204654.html 2026-09-01T21:55:44+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/intra-cerebrovascular-stroke-ich-model-prisys-79204660.html 2026-09-01T21:55:42+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/non-na-ve-nhps-in-preclinical-trials-a-cost-e-79204679.html 2026-09-01T21:55:46+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/advancing-immunology-and-inflammation-research-79204681.html 2026-09-01T21:55:42+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/direct-delivery-of-oligonucleotide-drugs-to-th-79205153.html 2024-11-09T10:34:50+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/revolutionizing-cns-drug-development-prisys-b-79487877.html 2026-09-01T21:55:47+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/cynomolgus-monkey-in-ophthalmic-drug-research-79487880.html 2026-09-01T21:55:45+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/prisys-nhp-models-immunology-inflammatio-79487882.html 2026-09-01T21:55:41+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/pk-strategies-of-pdc-79553957.html 2026-09-01T21:55:41+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/preclinical-animal-studies-1-animal-specie-79553960.html 2026-09-01T21:55:40+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/integrating-cns-safety-evaluation-into-79553966.html 2026-09-01T21:55:40+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/clinical-pathology-data-interpretation-challen-79553967.html 2026-09-01T21:55:57+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/the-role-of-aav-in-gene-therapy-immune-respon-79553968.html 2026-09-01T21:55:43+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79553969.html 2026-09-01T21:55:46+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/nonclinical-safety-evaluation-of-ocular-drug-d-79553970.html 2026-09-01T21:55:43+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/advancing-cns-and-cgt-research-prisys-biotech-79553971.html 2026-09-01T21:55:44+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79553972.html 2026-09-01T21:55:45+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/advancing-sirna-therapeutics-overcoming-chall-79553975.html 2026-09-01T21:55:45+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/application-prospects-of-gene-drugs-based-on-l-79553976.html 2026-09-01T21:55:42+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/how-to-conduct-preclinical-pharmacology-toxico-79553977.html 2026-09-01T21:55:43+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/non-human-primate-cerebrospinal-fluid-collecti-79553978.html 2026-09-01T21:55:43+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/considerations-for-interpreting-clinical-patho-79553979.html 2026-09-01T21:55:44+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/how-to-evaluate-the-safety-of-skin-products-be-79553980.html 2026-09-01T21:55:47+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/optimized-nonclinical-immunogenicity-evaluatio-79553981.html 2026-09-01T21:55:45+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/how-to-evaluate-preclinical-pharmacological-ef-79553982.html 2026-09-01T21:55:48+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/how-drugs-move-and-change-in-our-bodies-a-bri-79553983.html 2026-09-01T21:55:46+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/insight-into-the-sensory-and-behavioral-traits-79553984.html 2026-09-01T21:55:48+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/how-to-develop-new-drugs-faster-and-safer-a-g-79553985.html 2026-09-01T21:55:47+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/key-points-in-designing-strategies-for-non-79553986.html 2026-09-01T21:55:48+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/liver-toxicity-as-a-key-concern-for-sirna-drug-79553987.html 2026-09-01T21:55:46+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/the-vital-role-of-experimental-monkeys-in-adva-79553988.html 2026-09-01T21:55:49+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/the-significant-role-of-experimental-monkeys-i-79553989.html 2026-09-01T21:55:51+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/how-to-deliver-biologics-to-the-brain-79553990.html 2026-09-01T21:55:46+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/revolutionizing-metabolic-disease-treatment-a-79553991.html 2026-09-01T21:55:49+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/the-importance-of-translational-medicine-resea-79553992.html 2026-09-01T21:55:50+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/prisys-biotechnology-novel-lipid-nanoparticle-79553993.html 2026-09-01T21:55:50+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/the-main-factors-considered-in-woe-analysis-79553994.html 2026-09-01T21:55:45+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/understanding-macaca-fascicularis-cynomolgus-79553995.html 2026-09-01T21:55:43+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/reducing-the-use-of-nonhuman-primates-in-noncl-79553996.html 2026-09-01T21:55:51+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79553997.html 2026-09-01T21:56:03+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/brief-introduction-about-biological-analysis-o-79553998.html 2026-09-01T21:55:51+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/mrna-based-therapies-past-79553999.html 2026-09-01T21:55:46+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/group-housing-guidelines-for-laboratory-monkey-79554000.html 2026-09-01T21:55:51+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/factors-to-consider-for-the-immunogenicity-of-79554002.html 2026-09-01T21:55:50+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/pharmacodynamic-pd-evaluation-of-gene-therap-79554003.html 2026-09-01T21:56:00+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/chinese-scientists-offers-new-strategies-to-re-79554004.html 2026-09-01T21:55:59+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79554005.html 2026-09-01T21:55:51+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/mrna-based-therapies-present-79554006.html 2026-09-01T21:56:11+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/preclinical-animal-studies-2-routes-and-vo-79554007.html 2026-09-01T21:55:53+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/mrna-based-therapies-future-and-challenges-79554008.html 2026-09-01T21:55:55+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/lcms-preclinical-bioanalysis-of-lnp-based-gene-79554009.html 2026-09-01T21:55:52+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/significance-principles-and-requirements-of-79554010.html 2026-09-01T21:55:56+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/mrna-a-powerful-and-versatile-tool-for-fighti-79554011.html 2026-09-01T21:55:44+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/reflections-on-non-clinical-pharmacology-studi-79554231.html 2026-09-01T21:55:47+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/nonclinical-study-evaluation-q-a-79554232.html 2026-09-01T21:56:07+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/advancements-in-cns-research-ced-imri-79656492.html 2026-09-01T21:55:58+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/convection-enhanced-delivery-81244375.html 2026-09-01T21:56:02+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/the-importance-of-preclinical-pharmacodynamics-81244376.html 2026-09-01T21:55:54+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/intranasal-administration-in-animal-studies-81244377.html 2026-09-01T21:56:02+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/rtimri-for-parkinsons-disease-81244378.html 2026-09-01T21:55:57+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/innovations-in-pain-evaluation-ai-driven-beha-81244379.html 2026-09-01T21:56:01+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/advanced-cns-delivery-techniques-in-cynomolgus-81244380.html 2026-09-01T21:56:05+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/animal-models-of-human-diseases-81244383.html 2026-09-01T21:55:57+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/china-experimental-monkey-industry-81244385.html 2026-09-01T21:55:56+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/cynomolgus-monkey-chronic-kidney-disease-model-81244386.html 2026-09-01T21:56:05+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/compartment-pk-model-81244387.html 2026-09-01T21:55:59+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/human-disease-animal-models-81244388.html 2026-09-01T21:56:04+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/dmpk-evaluation-of-central-nervous-system-cns-81244389.html 2026-09-01T21:56:08+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/cynomolgus-monkey-mcao-model-81244390.html 2026-09-01T21:56:11+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/advances-in-mrna-pulmonary-delivery-systems-an-82278031.html 2026-09-01T22:02:25+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/pharmacodynamics-evaluation-of-adcs-82739112.html 2026-09-01T22:02:26+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/understanding-the-dmpk-of-adc-drugs-82739113.html 2026-09-01T22:02:35+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/pharmacokinetics-evaluation-of-antibody-drug-c-82739115.html 2026-09-01T22:02:30+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/comprehensive-preclinical-safety-evaluation-of-82739116.html 2026-09-01T21:56:09+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/pharmacokinetic-pk-considerations-for-centra-82739118.html 2026-09-01T22:02:33+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/prisys-biotech-establishes-cynomolgus-monkey-p-82739123.html 2026-09-01T22:02:24+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/progress-in-the-development-of-nucleic-acid-dr-82739135.html 2026-09-01T22:09:42+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/comprehensive-non-human-primate-models-for-ren-82739138.html 2026-09-01T21:56:55+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/2024-nobel-prize-in-physiology-or-medicine-82739570.html 2026-09-01T22:02:37+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/ocular-toxicity-studies-of-eye-drops-drug-exp-83052350.html 2026-09-01T22:02:39+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/drug-delivery-strategies-for-brain-diseases-83052355.html 2026-09-01T22:02:29+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/real-time-intraoperative-mri-navigation-suppo-83133673.html 2026-09-01T22:02:34+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/potential-routes-for-biologics-to-brain-83977152.html 2026-09-01T22:02:43+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/nonclinical-drug-development-guide-toxicity-83977153.html 2026-09-10T15:42:22+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/advancing-rheumatoid-arthritis-ra-research-w-83977155.html 2026-09-10T15:42:22+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/the-critical-role-of-animal-models-in-human-di-83977156.html 2026-09-01T22:02:33+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/minipig-as-nonclinical-large-animal-83977157.html 2026-09-10T15:42:22+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/nasal-to-brain-n2b-drug-delivery-83977158.html 2026-09-01T22:02:41+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/animal-models-for-atopic-dermatitis-83977159.html 2026-09-01T22:02:39+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/parkin-gene-deficiency-monkey-model-reveals-ne-83977160.html 2026-09-10T15:42:22+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/prisys-annual-report-2024-advancing-nhp-model-83978127.html 2026-09-10T15:42:22+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/meet-prisys-in-2025-us-roadshow-17243135370961920.html 2026-09-01T22:02:48+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/selecting-the-ideal-non-human-primate-for-toxi-17243135766635520.html 2026-09-01T22:02:38+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/animal-models-challenges-and-applications-in-17295197813433344.html 2026-07-22T10:23:29+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/animal-brain-stereotactic-instruments-17295197823656960.html 2026-09-10T15:42:22+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/non-human-primate-model-for-rheumatoid-arthrit-17295197883573248.html 2026-09-10T15:42:22+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/integration-of-pharmacokinetics-and-pharmacody-17295197902152704.html 2026-07-22T10:23:31+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/membranous-nephropathy-model-17295197923877888.html 2026-09-01T22:02:36+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/animal-models-for-womens-health-17295197933134848.html 2026-09-01T22:03:30+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/what-does-proof-of-concept-poc-in-drug-devel-17295197933872128.html 2026-09-01T22:02:34+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/microbial-testing-and-its-impact-on-nhp-17295197984531456.html 2026-09-10T15:42:22+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/cynomolgus-monkey-endometriosis-model-17295198095647744.html 2026-07-22T10:23:25+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/animal-models-for-in-vivo-testing-1-establi-17295198150468608.html 2026-09-01T22:02:55+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/nonclinical-pharmacodynamic-research-17295198150992896.html 2026-09-10T15:42:22+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/world-obesity-day-nhp-metabolic-models-17295198227293184.html 2026-09-01T22:02:37+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/systemic-lupus-erythematosus-sle-and-the-rol-17295231125021696.html 2026-09-10T15:42:22+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-monkey-psoriasis-m-17295231344780288.html 2026-07-22T10:23:09+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/nonclinical-immunotoxicity-assessment-strateg-17295231345714176.html 2026-09-01T22:02:33+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/pharmacokinetics-of-inhaled-drugs-17295231445066752.html 2026-07-22T10:23:21+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/targeting-interleukin-31-autoimmune-disease-17298492801639424.html 2026-09-01T22:02:44+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/aso-pharmacokinetics-absorption-17374210729976832.html 2026-07-22T10:23:19+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/intracerebral-icm-injection-precision-targe-17374210802934784.html 2026-07-22T10:23:24+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/advancing-parkinson-s-disease-research-with-th-17374210814583808.html 2026-09-01T22:02:57+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/asthma-research-why-non-human-primate-models-17374210849088512.html 2026-09-10T15:42:22+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/pharmacokinetics-pk-key-parameters-17374210850104320.html 2026-09-01T22:02:58+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/intrathecal-it-injection-a-direct-cns-deliv-17374210910725120.html 2026-07-22T10:23:45+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/advanced-preclinical-inhalation-studies-techn-17374210928452608.html 2026-07-22T10:23:36+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/intracerebroventricular-icv-injection-17374210928944128.html 2026-07-22T10:23:50+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/nhp-inhalation-studies-for-biologics-prisys-17374211138315264.html 2026-07-22T10:23:10+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/designing-animal-studies-key-considerations-f-17374211182846976.html 2026-09-10T15:42:22+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/atopic-dermatitis-how-cynomolgus-monkey-model-17374254581752832.html 2026-07-22T10:23:29+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/preclinical-pk-pd-studies-nhp-models-17374254898865152.html 2025-07-24T09:18:17+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/nhp-model-platforms-to-support-drug-developmen-17456023023821824.html 2026-07-22T10:23:12+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/guiding-principles-for-animal-species-selectio-17456023109329920.html 2026-09-01T22:02:53+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/cynomolgus-monkey-pain-models-17456023134086144.html 2026-09-10T15:42:22+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/prisys-biotech-s-nhp-atopic-dermatitis-model-f-17456023202178048.html 2026-07-22T10:23:15+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/a-guide-to-anti-drug-antibody-ada-assessment-17456023204144128.html 2025-07-24T09:18:34+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/nhp-pain-models-accelerating-analgesic-drug-d-17456023237043200.html 2026-09-01T22:03:00+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/prisys-biotech-s-advanced-dsa-and-imri-for-hem-17456023282541568.html 2025-07-24T09:18:27+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/advancing-atopic-dermatitis-research-prisys-b-17456023287391232.html 2026-07-22T10:23:14+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/engineered-exosomes-revolutionizing-drug-deli-17456023389479936.html 2025-07-24T09:18:30+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/prisys-biotech-2025-mid-year-review-17456023679214592.html 2026-07-22T11:03:06+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/key-considerations-for-dosing-volume-17456023868171264.html 2026-09-01T22:03:01+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/respiratory-therapies-prisys-biotech-s-integr-17456036290831360.html 2026-09-10T15:42:22+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/pruritus-research-il-31-nhp-itch-model-17501405140804608.html 2026-09-10T15:42:22+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/nhp-acute-hemorrhage-model-17501405144146944.html 2026-09-10T15:42:22+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/nhp-copd-model-17501405321257984.html 2026-09-01T22:02:51+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/preclinical-dosing-guidelines-iv-po-volume-17501405326812160.html 2026-09-01T22:03:11+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/serum-vs-plasma-choosing-the-optimal-matrix-17501405348471808.html 2026-09-10T15:42:22+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/nhp-pain-models-for-translational-drug-discove-17501405372015616.html 2026-09-10T15:42:22+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/idiopathic-pulmonary-fibrosis-ipf-nhp-model-17530064809026560.html 2026-09-01T22:02:46+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/cynomolgus-monkey-biodistribution-study-17530064906806272.html 2026-09-10T15:42:22+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/meet-prisys-biotech-at-upcoming-eu-roadshow-17530064929629184.html 2026-09-10T15:42:22+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/brain-targeted-drug-delivery-17530064994821120.html 2026-09-10T15:42:22+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/nhp-models-for-hematology-and-stroke-17530065020544000.html 2026-07-22T10:23:33+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/adc-drug-development-translational-pk-pd-fra-17530065022346240.html 2026-09-10T15:42:22+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/the-importance-of-administration-volume-17530065070220288.html 2026-09-01T22:02:54+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/cynomolgus-rhesus-monkey-models-prisys-bio-17540028019827712.html 2026-09-10T15:42:22+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/nhp-based-pharmacology-and-pharmacodynamic-17559595305804800.html 2026-09-01T22:02:46+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/shr-2004-a-breakthrough-in-vte-prevention-for-17630671022351360.html 2026-09-10T15:42:22+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/nasal-to-brain-n2b-delivery-technology-for-c-17630671050957824.html 2026-09-10T15:42:22+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/nhp-ai-based-behavioral-analysis-17630671288542208.html 2026-09-10T15:42:22+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/rfp-template-for-nhp-studies-17630671317230592.html 2026-07-22T10:23:48+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/nhp-renal-biopsy-17630671382799360.html 2026-09-01T22:03:01+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/pk-study-targeted-drug-delivery-17630671501878272.html 2026-09-01T22:02:59+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/cold-allodynia-pain-model-in-cynomolgus-monkey-17630671787729920.html 2026-09-01T22:02:50+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/mri-guided-intracerebral-drug-delivery-17630672848413696.html 2026-07-22T10:23:21+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/th17-driven-nhp-immunology-models-17630673361347584.html 2026-09-10T15:42:22+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/nhp-respiratory-disease-models-and-airway-drug-17630673926562816.html 2026-09-10T15:42:22+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/ai-based-nhp-behavioratlas-system-3d-behavi-17631382216664064.html 2026-09-01T22:03:00+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/how-to-choose-a-reliable-preclinical-cro-key-17674682319184896.html 2026-07-22T10:23:42+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/parkinsons-disease-preclinical-models-17674682511975424.html 2026-09-10T15:42:22+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/high-precision-drug-delivery-and-ai-driven-nhp-17674686179632128.html 2026-09-10T15:42:22+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/ai-driven-markerless-3d-behavioral-analysis-17674686245331968.html 2025-12-25T20:25:15+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/one-to-multi-compartment-pk-models-17674686327841792.html 2025-12-25T20:25:13+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/lps-induced-acute-lung-inflammation-ali-nhp-17674686353286144.html 2026-09-10T15:42:22+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/hdm-seb-induced-atopic-dermatitis-atd-model-17674686394409984.html 2026-07-22T10:23:24+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/cns-drug-candidates-in-preclinical-study-17674697587778560.html 2025-12-27T17:27:41+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/translational-car-t-evaluation-in-vitro-17677333901403136.html 2026-01-29T22:42:37+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/non-human-primate-mash-associated-liver-fibros-17724350011859968.html 2026-01-29T22:42:42+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/multi-endpoint-pain-assessment-the-future-17724350018692096.html 2026-01-29T22:42:43+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/2025-recap-how-prisys-is-redefining-translati-17724350141391872.html 2026-01-29T22:42:44+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/uric-acid-metabolism-in-humans-vs-monkeys-17724350159479808.html 2026-01-29T22:42:39+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/non-human-primate-models-are-critical-cns-17724350191477760.html 2026-01-29T22:42:46+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/emotional-memory-chronic-pain-nhp-models-17724350195835904.html 2026-01-29T22:43:06+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/blood-sampling-time-point-in-pharmacokinetic-17724350302905344.html 2026-01-29T22:42:46+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/imri-guided-brain-drug-delivery-17724350391755776.html 2026-09-10T15:42:22+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/analgesics-fail-in-preclinical-measure-pain-17724371153953792.html 2026-09-10T15:42:22+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/pk-statistical-analysis-nca-parameters-guide-17724371412198400.html 2026-09-10T15:42:22+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/ai-markerless-nhp-3d-behavior-analysis-system-17853531534271488.html 2026-09-10T15:42:22+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/mri-guided-cns-delivery-in-nhp-models-17853531569988608.html 2026-09-10T15:42:22+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/evaluating-dmpk-properties-17853531576558592.html 2026-09-10T15:42:22+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/ipf-drug-development-nhp-ct-imaging-pft-17853531637441536.html 2026-09-10T15:42:22+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/drug-development-reliance-on-nhp-models-17853531718820864.html 2026-09-10T15:42:22+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/nhp-cns-biodistribution-studies-intrathecal-17853531837686784.html 2026-09-10T15:42:22+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/translational-pk-pd-framework-cynomolgus-17853531864998912.html 2026-09-10T15:42:22+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/nonlinear-pharmacokinetics-nhp-pkpd-17853542177432576.html 2026-05-01T04:56:29+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/pet-ct-biodistribution-in-nhp-models-for-cns-17853542386721792.html 2026-05-01T04:56:26+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/nhp-av-shunt-thrombosis-model-antibody-safety-17853542417720320.html 2026-05-01T04:56:25+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/in-vivo-immune-cell-tracking-17853542460695552.html 2026-05-01T04:56:40+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/prisys-supports-ind-approval-of-ux-gip001-17853542481404928.html 2026-05-01T04:56:31+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/non-glp-pharmacology-data-integrity-17853542501360640.html 2026-05-01T04:56:29+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/dopamine-transporter-pet-imaging-in-nhp-models-17853542526100480.html 2026-05-01T04:56:32+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/nonclinical-pharmacokinetics-strategy-17853542607250432.html 2026-05-01T05:11:11+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/large-animal-radiolabeling-and-in-vivo-imaging-17853555986310144.html 2026-07-22T14:22:26+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/on-demand-webinar-mri-ced-nhp-17888417422238720.html 2026-05-25T20:10:58+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/nhp-models-translational-drug-development-17888417474946048.html 2026-07-22T14:22:33+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/pk-data-as-translational-biomarker-17888417520935936.html 2026-05-25T20:10:59+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/non-human-primate-models-of-pulmonary-fibrosis-17888417558045696.html 2026-05-25T20:11:14+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/pk-data-as-pharmacodynamic-biomarker-17888417847976960.html 2026-07-22T14:22:55+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/nhp-av-shunt-thrombosis-model-17946816935339008.html 2026-07-22T14:22:34+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/nonlinear-pharmacokinetics-explained-17946816981525504.html 2026-07-22T14:22:57+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/what-is-molecular-imaging-drug-development-17946817037247488.html 2026-07-22T14:22:21+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/nhp-heart-failure-model-17946817050436608.html 2026-07-22T14:06:37+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/nhp-molecular-imaging-translational-pet-studie-17946817053320192.html 2026-07-22T14:22:46+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/dsa-cta-cardiovascular-drug-safety-imaging-17946817056187392.html 2026-07-22T14:22:42+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/nhp-radionuclide-biodistribution-17946817067738112.html 2026-07-22T14:22:24+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/molecular-imaging-biomarkers-advancing-transl-17946817792877568.html 2026-07-22T10:23:23+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/clinical-pathology-interpretation-dogs-nhp-17946834176320512.html 2026-09-10T15:42:22+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/pain-mechanisms-the-uvb-sunburn-model-17969954762171392.html 2026-09-10T15:42:22+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/nhp-models-of-maternal-high-fat-diet-and-child-17969954844353536.html 2026-09-10T15:42:22+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/ai-nhp-behavioral-analysis-17969954904941568.html 2026-09-10T15:42:22+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/nhp-behavioratlas-3d-behavioral-tracking-17969955061588992.html 2026-07-27T13:38:56+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/baseline-ada-screening-washed-out-monkeys-17977211253351424.html 2026-07-27T13:38:15+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/markerless-3d-nhp-behavior-analysis-17977211318887424.html 2026-07-27T13:38:21+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/nhp-aav-gene-therapy-model-mri-guided-ced-17977211336303616.html 2026-08-23T13:30:15+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/webinar-nhp-behavioratlas-17977211459822592.html 2026-07-27T13:38:55+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/when-to-introduce-nhp-studies-autoimmune-drug-17977211658183680.html 2026-07-27T13:39:26+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/nhp-ibd-model-chronic-enterocolitis-17977212231214080.html 2026-07-27T13:38:50+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/why-positive-control-drugs-matter-in-autoimmun-17977212615451648.html 2026-08-02T16:34:45+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/midd-and-nhp-efficacy-models-in-drug-17985882545005568.html 2026-08-02T16:34:10+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/behavior-in-rhesus-17985882551116800.html 2026-08-05T21:38:25+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/pk-biomarkers-preclinical-drug-development-17990428479038464.html 2026-09-01T22:02:46+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/webinar-recap-digital-behavioral-phenotyping-17993114039690240.html 2026-09-01T22:02:48+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/pbpk-vs-compartmental-models-drug-development-18003172447216640.html 2026-09-01T22:02:44+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/molecular-imaging-in-nhp-model-webinar-18003172470432768.html 2026-09-01T22:02:47+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/3d-ai-tracking-nhp-behavior-18015428043351040.html 2026-08-23T15:10:41+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/pet-biodistribution-nhp-studies-18015526528590848.html 2026-09-01T22:02:59+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/quantitative-pet-target-engagement-in-nhps-for-18021170993079296.html 2026-09-01T11:53:34+08:00 weekly 0.8 https://sk.prisysbiotech.com/news/animal-models-succeed-or-fail-in-drug-dev-18028073085920256.html 2026-02-06T06:16:55+08:00 weekly 0.8 https://sk.prisysbiotech.com/blog/how-do-nhp-preclinical-studies-help-in-the-development-of-geriatric-drugs-2844578.html 2026-02-12T04:51:27+08:00 weekly 0.8 https://sk.prisysbiotech.com/blog/how-are-nhps-selected-for-a-study-2921463.html 2026-02-27T06:19:51+08:00 weekly 0.8 https://sk.prisysbiotech.com/blog/what-are-the-advantages-of-using-an-nhp-cro-3016066.html 2026-03-03T06:29:07+08:00 weekly 0.8 https://sk.prisysbiotech.com/blog/what-is-the-pharmacokinetic-profile-of-inhaled-drugs-3053038.html 2026-03-10T06:10:54+08:00 weekly 0.8 https://sk.prisysbiotech.com/blog/how-do-pd-drugs-influence-the-immune-cells-in-the-brain-in-pharmacology-3122306.html 2026-03-24T05:34:31+08:00 weekly 0.8 https://sk.prisysbiotech.com/blog/how-to-measure-the-infarct-volume-in-the-mcao-nhp-model-3321686.html 2026-04-24T07:01:49+08:00 weekly 0.8 https://sk.prisysbiotech.com/blog/pk-pd-clinical-implications-3748810.html 2026-05-18T04:52:20+08:00 weekly 0.8 https://sk.prisysbiotech.com/blog/nhp-preclinical-studies-drug-development-significance-4028209.html 2026-06-05T04:40:58+08:00 weekly 0.8 https://sk.prisysbiotech.com/blog/mcao-nhp-model-post-stroke-brain-network-reorganization-4317703.html 2026-06-08T05:14:11+08:00 weekly 0.8 https://sk.prisysbiotech.com/blog/cynomolgus-vs-rhesus-monkey-preclinical-research-4336037.html 2026-06-15T05:05:32+08:00 weekly 0.8 https://sk.prisysbiotech.com/blog/pharmacodynamic-model-limitations-translational-nhp-studies-4439338.html 2026-06-29T05:46:12+08:00 weekly 0.8 https://sk.prisysbiotech.com/blog/how-to-validate-a-pharmacokinetic-model-4620735.html 2026-07-22T04:46:23+08:00 weekly 0.8 https://sk.prisysbiotech.com/blog/what-is-the-impact-of-gender-on-pk-pharmacolog-4975100.html 2026-08-05T04:59:18+08:00 weekly 0.8 https://sk.prisysbiotech.com/blog/non-human-primate-accelerate-rheumatology-dev-5213201.html 2026-08-11T06:08:06+08:00 weekly 0.8 https://sk.prisysbiotech.com/blog/pharmacokinetic-study-design-drug-development-5320421.html 2026-08-21T04:34:25+08:00 weekly 0.8 https://sk.prisysbiotech.com/blog/minimum-sample-size-nhp-preclinical-studies-5531710.html 2026-09-04T06:29:31+08:00 weekly 0.8 https://sk.prisysbiotech.com/blog/how-does-rna-mediated-immune-response-impact-drug-pk-5778424.html